Avacta Group Plc (AIM:AVCT)
London · Delayed Price · Currency is GBP · Price in GBX 58.00
0.00 (0.00%)
At close: Dec 31, 2025
Avacta Group Market Cap
Avacta Group has a market cap or net worth of 251.39 million as of December 31, 2025. Its market cap has increased by 52.68% in one year.
Market Cap
251.39M
Enterprise Value
259.15M
Revenue
113.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
58.00
Market Cap Chart
Since September 29, 2006, Avacta Group's market cap has increased from 37.46M to 251.39M, an increase of 571.10%. That is a compound annual growth rate of 10.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 251.39M | 37.41% |
| Dec 31, 2024 | 182.95M | -43.88% |
| Dec 29, 2023 | 325.99M | 9.26% |
| Dec 30, 2022 | 298.35M | -5.82% |
| Dec 31, 2021 | 316.78M | 11.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 213.19B |
| GSK plc | 73.15B |
| Haleon | 33.22B |
| Smith & Nephew | 10.43B |
| Convatec Group | 4.74B |
| Hikma Pharmaceuticals | 3.40B |
| Genus | 1.73B |
| HUTCHMED (China) | 1.71B |